Skip to content

Clinical study to find out the safety and efficacy of a polyherbal local anaesthetic parenteral formulation

An open label safety and efficacy study of a polyherbal local anaesthetic parenteral formulation by estimating pharmacokinetic parameters in healthy adults

Status
Active, not recruiting
Phases
Phase 1Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/04/042091
Enrollment
10
Registered
2022-04-22
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

None listed

Sponsors

Pankajakasthuri Herbals India Pvt Ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Healthy volunteers Has a legally acceptable representative capable of under standing the informed consent documents and providing consent on the participants behalf Normal laboratory values in CBC, LFT and RFT Non smokers, non substance abusers, non alcoholic

Exclusion criteria

Exclusion criteria: 1. Pregnant or breastfeeding women. 2. Body mass index superior to 35�kg/m2. 3. Allergy to any one of the ingredients in the formulation. 4. Uncontrolled hypertension/congenital heart problems. 5. Life-threatening comorbidities. 6. Adults legally protected (under judicial protection, guardianship or supervision) and persons deprived of their liberty. 7. Those who are taking regular medication 8. Any other chronic illness

Design outcomes

Primary

MeasureTime frame
The primary out of the study is to assess the safety and efficacy on single-dose administration of polyherbal local anaesthetic formulation in healthy adults. The next objective is to assess the tolerability and safety profiles on single dose administration of polyherbal local anaesthetic in the test subjects Timepoint: During the therapy

Secondary

MeasureTime frame
ï?¶ Checking the Nociception, Touch and Pain sensation up to 60 minutes ï?¶ To find out any other therapeutic properties like antiinflammatory activity. Timepoint: During therapy

Countries

India

Contacts

Public ContactShan Sasidharan

Pankajakasthuri Herbal Research Foundation

drshan@pkhil.com09188325339

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026